AQP1 and familial dilated cardiomyopathy: Similarly, AQP1 and AQP4 are likely to play a beneficial role in DCM resulting from a pharmacological study evaluating the effects of the antidiabetic treatment Empaglifozin (EMPA) in type 2 diabetic rats [61].